Edition:
India

People: Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

32.10CAD
25 Jun 2019
Change (% chg)

-- (--)
Prev Close
$32.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
858,140
52-wk High
$36.52
52-wk Low
$23.60

von Eschenbach, Andrew 

Dr. Andrew C. von Eschenbach is Independent Director of the Company. Dr. von Eschenbach was appointed acting commissioner of the U.S. Food and Drug Administration in 2005, was later confirmed by the Senate as commissioner in 2006 and then held the role until his resignation in 2009. Prior to that, he served as director of the National Cancer Institute at the National Institutes of Health from 2002 to 2006. Dr. von Eschenbach also previously served as a physician, surgeon, oncologist and executive at the University of Texas MD Anderson Cancer Center from 1976 until 2002, and since 2009, he has continued to serve as an adjunct professor there. He also currently serves as president of Samaritan Health Initiative and as a senior fellow at the Milken Institute. Dr. von Eschenbach earned a B.S. from St. Joseph's University and a M.D. from Georgetown University. Following medical school, he served as a lieutenant commander in the U.S. Naval Medical Corps. He completed his residency at Pennsylvania Hospital in Philadelphia and served as an instructor in Urology at the University of Pennsylvania School of Medicine. He then completed a fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joseph Papa

4,895,110

Paul Herendeen

2,597,950

Christina Ackermann

2,795,150

Thomas Appio

3,429,290

William Humphries

8,434,210

Thomas Ross

445,880
As Of  31 Dec 2017